Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
British journal of cancer. - 124 (2021) , 1611, ISSN: 1532-1827
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
-
Hajiev, Saur
Allara, Elias
Motedayеn-Aval, Leila
Arizumi, Tadaaki
Bettinger, Dominik
Pirisi, Mario
Rimassa, Lorenza
Pressiani, Tiziana
Personeni, Nicola
Giordano, Laura
Kudo, Masatoshi
Thimme, Robert
Park, Joong Won
Taddei, Tamar H.
Kaplan, David E.
Ramaswami, Ramya
Pinato, David James
Sharma, Rohini
- DOI
-
10.1038/s41416-020-01241-5
- URN
-
urn:nbn:de:bsz:25-freidok-1936442
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hajiev, Saur
- Allara, Elias
- Motedayеn-Aval, Leila
- Arizumi, Tadaaki
- Bettinger, Dominik
- Pirisi, Mario
- Rimassa, Lorenza
- Pressiani, Tiziana
- Personeni, Nicola
- Giordano, Laura
- Kudo, Masatoshi
- Thimme, Robert
- Park, Joong Won
- Taddei, Tamar H.
- Kaplan, David E.
- Ramaswami, Ramya
- Pinato, David James
- Sharma, Rohini
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment
Fibrosis progression in patients with Budd–Chiari syndrome and transjugular intrahepatic portosystemic shunt (TIPS): a long-term study using transient elastography
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment
Fibrosis progression in patients with Budd–Chiari syndrome and transjugular intrahepatic portosystemic shunt (TIPS): a long-term study using transient elastography
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Toward a better understanding of hepatocellular carcinoma immune infiltrates
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment
Fibrosis progression in patients with Budd–Chiari syndrome and transjugular intrahepatic portosystemic shunt (TIPS): a long-term study using transient elastography
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach